Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science, [2004]-
    • الموضوع:
    • نبذة مختصرة :
      Background: The NHS Diabetes Prevention Programme (NDPP) is a behaviour change programme for adults who are at risk of developing type 2 diabetes mellitus (T2DM): people with raised blood glucose levels, but not in the diabetic range, diagnosed with nondiabetic hyperglycaemia (NDH). We examined the association between referral to the programme and reducing conversion of NDH to T2DM.
      Methods and Findings: Cohort study of patients attending primary care in England using clinical Practice Research Datalink data from 1 April 2016 (NDPP introduction) to 31 March 2020 was used. To minimise confounding, we matched patients referred to the programme in referring practices to patients in nonreferring practices. Patients were matched based on age (≥3 years), sex, and ≥365 days of NDH diagnosis. Random-effects parametric survival models evaluated the intervention, controlling for numerous covariates. Our primary analysis was selected a priori: complete case analysis, 1-to-1 practice matching, up to 5 controls sampled with replacement. Various sensitivity analyses were conducted, including multiple imputation approaches. Analysis was adjusted for age (at index date), sex, time from NDH diagnosis to index date, BMI, HbA1c, total serum cholesterol, systolic blood pressure, diastolic blood pressure, prescription of metformin, smoking status, socioeconomic status, a diagnosis of depression, and comorbidities. A total of 18,470 patients referred to NDPP were matched to 51,331 patients not referred to NDPP in the main analysis. Mean follow-up from referral was 482.0 (SD = 317.3) and 472.4 (SD = 309.1) days, for referred to NDPP and not referred to NDPP, respectively. Baseline characteristics in the 2 groups were similar, except referred to NDPP were more likely to have higher BMI and be ever-smokers. The adjusted HR for referred to NDPP, compared to not referred to NDPP, was 0.80 (95% CI: 0.73 to 0.87) (p < 0.001). The probability of not converting to T2DM at 36 months since referral was 87.3% (95% CI: 86.5% to 88.2%) for referred to NDPP and 84.6% (95% CI: 83.9% to 85.4%) for not referred to NDPP. Associations were broadly consistent in the sensitivity analyses, but often smaller in magnitude. As this is an observational study, we cannot conclusively address causality. Other limitations include the inclusion of controls from the other 3 UK countries, data not allowing the evaluation of the association between attendance (rather than referral) and conversion.
      Conclusions: The NDPP was associated with reduced conversion rates from NDH to T2DM. Although we observed smaller associations with risk reduction, compared to what has been observed in RCTs, this is unsurprising since we examined the impact of referral, rather than attendance or completion of the intervention.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2023 Ravindrarajah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      BMJ Open. 2020 Sep 6;10(9):e040201. (PMID: 32893192)
      BMJ Open Diabetes Res Care. 2020 Dec;8(2):. (PMID: 33303493)
      Diabetologia. 2006 Feb;49(2):289-97. (PMID: 16391903)
      BMJ Open Diabetes Res Care. 2020 Nov;8(2):. (PMID: 33214188)
      Diabetes Care. 1997 Apr;20(4):537-44. (PMID: 9096977)
      PLoS One. 2014 Jun 18;9(6):e99825. (PMID: 24941260)
      Can J Diabetes. 2018 Apr;42 Suppl 1:S10-S15. (PMID: 29650080)
      J Am Heart Assoc. 2018 Aug 21;7(16):e009428. (PMID: 30369322)
      Diabetes Care. 2010 Oct;33(10):2146-51. (PMID: 20664020)
      Nutrients. 2019 Nov 01;11(11):. (PMID: 31683759)
      Lancet. 2002 Jun 15;359(9323):2072-7. (PMID: 12086760)
      BMC Fam Pract. 2016 Aug 05;17:106. (PMID: 27495284)
      BMJ Open. 2016 Jan 13;6(1):e010210. (PMID: 26769791)
      BMC Health Serv Res. 2019 Dec 23;19(1):991. (PMID: 31870371)
      Lancet. 2006 Sep 23;368(9541):1096-105. (PMID: 16997664)
      JAMA Intern Med. 2017 Dec 1;177(12):1808-1817. (PMID: 29114778)
      Diabetes Care. 2014 Apr;37(4):934-42. (PMID: 24319121)
      Int J Epidemiol. 2015 Jun;44(3):827-36. (PMID: 26050254)
      J Chronic Dis. 1987;40(5):373-83. (PMID: 3558716)
      Diagn Progn Res. 2018 Jan 10;2:1. (PMID: 31093551)
      Diabetes Care. 2004 Jan;27(1):155-61. (PMID: 14693982)
      BMC Fam Pract. 2010 Jan 05;11:1. (PMID: 20051110)
      BMJ. 2013 Jan 16;346:f114. (PMID: 23325866)
      Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461. (PMID: 31036503)
      BMJ. 2007 Feb 10;334(7588):299. (PMID: 17237299)
      Diabetes Care. 2020 Jan;43(1):152-160. (PMID: 31719054)
      N Engl J Med. 2001 May 3;344(18):1343-50. (PMID: 11333990)
      N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527)
      BMC Health Serv Res. 2020 Nov 27;20(1):1098. (PMID: 33246460)
      BMC Health Serv Res. 2020 Apr 15;20(1):307. (PMID: 32293424)
      Int J Epidemiol. 2019 Dec 1;48(6):1740-1740g. (PMID: 30859197)
      BMJ Open. 2016 May 13;6(5):e011664. (PMID: 27178981)
    • الرقم المعرف:
      2138-40-1 (4-nitro-3-dimethylaminopropiophenone)
    • الموضوع:
      Date Created: 20230227 Date Completed: 20230301 Latest Revision: 20230309
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC9970065
    • الرقم المعرف:
      10.1371/journal.pmed.1004177
    • الرقم المعرف:
      36848393